Investigation of selenium, intracellular selenium and selenoprotein P status in patients with inflammatory rheumatic diseases.
- Conditions
- psoriatic arthritisRheumatoid arthritispolyarthrosisjuvenile idiopathic arthritis
- Registration Number
- DRKS00031779
- Lead Sponsor
- MVZ Endokrinologikum Berlin am Gendarmenmarkt
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 290
Inclusion Criteria
one of the above-mentioned diagnoses from the group of inflammatory rheumatic diseases: rheumatoid arthritis; psoriatic arthritis; juvenile idiopathic arthritis; osteoarthritis
Patient consent
Exclusion Criteria
pregnancy, therapy with glucocorticoids >10mg prednisolone equivalent/day for >2 weeks, post organ transplantation, substitution with selenium.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Selenium status assessment in patients with inflammatory rheumatic diseases: Measurement of selenoprotein P by ELISA
- Secondary Outcome Measures
Name Time Method Correlation of disease activity of the underlying disease (DAS28) with selenium/selenoproteinP.